Certified by Founder Lodge
Juvena Therapeutics
United States - Palo Alto, CA
START UP
1 Disclosed Funding Rounds $33,500,000
0 Participating Investments
-
Founded date
2017
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Decoding Secreted Proteins for Chronic and Age-Related Diseases
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| January, 14 ,2026 | Series B | $33,500,000 |
Eli Lilly and Company
Bison Ventures
Jefferson Life Sciences
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Poetiq | $45,800,000 | (Feb 3, 2026)
1Buy.AI | $3,900,000 | (Feb 3, 2026)
Principle | $2,000,000 | (Feb 3, 2026)
Prenosis | $20,000,000 | (Feb 3, 2026)
PranaX | $17,000,000 | (Feb 3, 2026)
